SLU-PP-332 is a synthetic peptide under investigation for its potential to modulate aging-related pathways. It is reported to enhance mitochondrial function and reduce oxidative stress, which are key factors in cellular aging. Preclinical studies, primarily in animal models, suggest it may promote longevity and mitigate age-related decline. The peptide appears to influence pathways like AMPK or sirtuin signaling, which are associated with metabolic regulation and stress resistance. However, research remains in early stages, and its efficacy and safety in humans are not yet established. Further studies are required to validate these findings and explore therapeutic applications.